- With growth not coming, inflation won't be at 2%
Now that they're on pause mode, they are focusing more on dual risks to inflation. It's not just high prices but also the risk of undershooting now, at least that is what they are trying to sell.
Now that they're on pause mode, they are focusing more on dual risks to inflation. It's not just high prices but also the risk of undershooting now, at least that is what they are trying to sell.
Most Popular
MSFT's Azure revenue up 39%, NVDA trades at 21.6x forward earnings, AVGO AI chips grew 106%, TSM sees 60% AI chip CAGR.
NVDA's PEG <1x & P/B halved! With 100%+ ROE & $62B cash, it's undervalued.
PLTR doubles on revenue growth but trades at high multiples. NOW & CRM offer lower valuations with strong AI plays.
LEN & DHI down 49%/29% on housing woes. P/E 12 for LEN, strong dividends signal value.
Two dividend giants down 30-50%! BAM's 10-13% yield is a buy, but is the other?
MSFT's AI push fuels 17% revenue growth & 50% upside potential. New E7 tier at $99/user boosts margins.
MMAs offer 4%+ APY, beating the 0.56% avg. Lock in high rates now before they fall!
Must Read